A cost-effectiveness analysis of coagulation testing prior to tonsillectomy and adenoidectomy in children

Pediatric Blood and Cancer

Volumn 55, Issue 6, 2010, Pages 1153-1159

  Cooper, James D ^a   Smith, Kenneth J ^b   Ritchey, A Kim ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Coagulation; Cost effectiveness; Decision analysis; Screening; Tonsillectomy

Indexed keywords

ADENOIDECTOMY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; DATA BASE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MEDICAL LITERATURE; PATIENT ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; TONSILLECTOMY;

ADENOIDECTOMY; BLOOD COAGULATION TESTS; CHILD; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS; TONSILLECTOMY;

EID: 77958528629     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22708     Document Type: Article

References (47)

1. Krishna P, Lee D. Post-tonsillectomy bleeding: A meta-analysis. Laryngoscope 2001; 111: 1358-1361.
2. Zwack GC, Derkay CS. The utility of preoperative hemostatic assessment in adenotonsillectomy. Int J Pediatr Otorhinolaryngol 1997; 39: 67-76.
3. Asaf T, Reuveni H, Yermiahu T, et al. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol 2001; 61: 217-222.
4. Kang J, Brodsky L, Danziger I, et al. Coagulation profile as a predictor for post-tonsillectomy and adenoidectomy (T+A) hemorrhage. Int J Pediatr Otorhinolaryngol 1994; 28: 157-165.
5. Tami TA, Parker GS, Taylor RE. Post-tonsillectomy bleeding: An evaluation of risk factors. Laryngoscope 1987; 97: 1307-1311.
6. Smith PS, Orchard PJ, Lekas MD. Predicting bleeding in common ear, nose, and throat procedures: A prospective study. R I Med J 1990; 73: 103-106.
7. Howells RC II, Wax MK, Ramadan HH. Value of preoperative prothrombin time/partial thromboplastin time as a predictor of postoperative hemorrhage in pediatric patients undergoing tonsillectomy. Otolaryngol Head Neck Surg 1997; 117: 628-632.
8. Derkay CS, Werner E, Plotnik E. Management of children with von Willebrand disease undergoing adenotonsillectomy. Am J Otolaryngol 1996; 17: 172-177.
9. Allen GC, Armfield DR, Bontempo FA, et al. Adenotonsillectomy in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg 1999; 125: 547-551.
10. Shah SB, Lalwani AK, Koerper MA. Perioperative management of von Willebrand's disease in otolaryngologic surgery. Laryngoscope 1998; 108: 32-36.
11. Federici AB, Sacco R, Stabile F, et al. Optimising local therapy during oral surgery in patients with von Willebrand disease: Effective results from a retrospective analysis of 63 cases. Haemophilia 2000; 6: 71-77.
12. Jimenez-Yuste V, Prim MP, Diego JID, et al. Otolaryngologic surgery in children with von Willebrand disease. Arch Otolaryngol Head Neck Surg 2002; 128: 1365-1368.
13. Manno CS, Butler RB, Farace L, et al. Successful management of patients with type 1 von Willebrand disease with desmopressin acetate for tonsillectomy. World Federation of Hemophilia, Abstracts of the XXIIIth International Congress. 1998; 288.
14. Nitu-Whalley IC, Griffioen A, Harrington C, et al. Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease. Am J Hematol 2001; 66: 280-284.
15. The American Academy of Otolaryngology-Head and Neck Surgery. Clinical Indicators Compendium. Alexandria, VA; 1999. Report.
16. Chee YL, Crawford JC, Watson HG, et al. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. Br J Haematol 2008; 140: 496-504.
17. Shaw PH, Reynolds S, Gunawardena S, et al. The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studies. J Pediatr Hematol Oncol 2008; 30: 135-141.
18. Gabriel P, Mazoit X, Ecoffey C. Relationship between clinical history, coagulation tests, and perioperative bleeding during tonsillectomies in pediatrics. J Clin Anesth 2000; 12: 288-291.
19. Eisert S, Hovermann M, Bier H, et al. Preoperative screening for coagulation disorders in children undergoing adenoidectomy (AT) and tonsillectomy (TE): Does it prevent bleeding complications? Klin Pädiatr 2006; 218: 334-339.
20. Close HL, Kryzer TC, Nowlin JH, et al. Hemostatic assessment of patients before tonsillectomy: A prospective study. Otolaryngol Head Neck Surg 1994; 111: 733-738.
21. Burk CD, Miller L, Handler SD, et al. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992; 89: 691-695.
22. Handler SD, Miller L, Richmond KH, et al. Post-tonsillectomy hemorrhage: Incidence, prevention and management. Laryngoscope 1986; 96: 1243-1247.
23. Bolger WE, Parsons DS, Potempa L. Preoperative hemostatic assessment of the adenotonsillectomy patient. Otolaryngol Head Neck Surg 1990; 103: 396-405.
24. Thomas GK, Arbon RA. Preoperative screening for potential T&A bleeding. Arch Otolaryngol 1970; 91: 453-456.
25. Manning SC, Beste D, McBride T, et al. An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol 1987; 13: 237-244.
26. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis: Part 1-Getting started. Med Decis Making 1997; 17: 123-125.
27. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis: Part 2-Building a tree. Med Decis Making 1997; 17: 126-135.
28. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 2005.
29. Naimark D, Krahn MD, Naglie G, et al. Primer on medical decision analysis: Part 5-Working with Markov processes. Med Decis Making 1997; 17: 152-159.
30. Sonnenberg FA, Beck JR. Markov models in medical decision making: A practical guide. Med Decis Making 1993; 13: 322-338.
31. Thomson Healthcare. Red Book. Montvale, NJ: Thomson Healthcare; 2008.
32. Covance Market Access Services, Inc. Hospital billing, coding, and payment for blood: Review of the basics, analysis of the OPPS guidelines, and 2007 update. Accessed June 17, 2008.
33. National Compensation Survey. U.S. Department of Labor, 2008.
34. Center for Medicare & Medicaid Services. U.S. Department of Health and Human Services. 2008.
35. Healthcare Cost & Utilization Project (HCUP). Agency for Healthcare Research and Quality. 2008.
36. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000; 38: 583-637.
37. O'Brien SH, Ritchey AK, Smith KJ. A cost-utility analysis of treatment for childhood acute idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer 2007; 48: 173-180.
38. O'Brien SH. Decision analysis in pediatric hematology. Pediatr Clin North America 2008; 55: 287-304.
39. Krahn MD, Naglie G, Naimark D, et al. Primer on medical decision analysis: Part 4-Analyzing the model and interpreting the results. Med Decis Making 1997; 17: 142-151.
40. Nichols WL. The diagnosis, evaluation, and management of von Willebrand disease. Bethesda, MD: National Heart Lung and Blood Institute; 2007. Report.
41. Bowman M, Riddel J, Rand ML, et al. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7: 1418-1421.
42. Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study. J Thromb Haemost 2005; 3: 2619-2626.
43. Rodeghiero F, Kadir RA, Tosetto A, et al. Relevance of quantitative assessment of bleeding in hemorrhagic disorders. Haemophilia 2008; 14: 68-75.
44. Tosetto A, Castaman G, Rodeghiero F. Assessing bleeding in von Willebrand disease with bleeding score. Blood Rev 2007; 21: 89-97.
45. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147-154.
46. Myssiorek D, Alvi A. Post-tonsillectomy hemorrhage: An assessment of risk factors. Int J Pediatr Otorhinolaryngol 1996; 37: 35-43.
47. Gold MR, Franks P, McCoy KI, et al. Toward consistency in cost-utility analyses: Using national measures to create condition-specific values. Med Care 1998; 36: 778-792.